'Eli Lilly Is Discontinuing Some Of Its Insulin Presentations Across Selected Countries; All Discontinuations Expected To Occur Before Q2 2027, After Which Affected Insulin Presentations Will No Longer Be Available'- European Medicines Agency

Eli Lilly is set to discontinue certain insulin presentations in selected countries, with all discontinuations expected to be completed before Q2 2027. After this period, the affected insulin products will no longer be available. This decision has been announced by the European Medicines Agency.